We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Epigenetic Signatures that Differentiate Triple-Negative Breast Cancers

News   Feb 03, 2015

 
Epigenetic Signatures that Differentiate Triple-Negative Breast Cancers
 
 
Advertisement
 

RELATED ARTICLES

Algorithms Uncover Cancers’ Unseen Genetic Losses and Gains

News

Scientists have created new mathematical tools that allow scientists to search the vast collection of DNA snippets and uncover whether there are either missing pieces or duplicates. These algorithms, dubbed HATCHet and CHISEL, could help to improve diagnosis and treatment.

READ MORE

Study of Over 1 Million People Suggests Blood Type O May Protect Against COVID-19

News

In June, Technology Networks reported on some of the initial findings from personal genomics and biotechnology company 23andMe's COVID-19 genetic study. These results lent further evidence to earlier suggestions that an individual's blood type – determined by a gene known as ABO – may be associated with COVID-19 susceptibility. Now, 23andMe scientists have published results from the first four months of the study which has collected data from over 1 million research participants.

READ MORE

Investigating How the Immune System Detects “Hidden” Threats

News

A new study has led to a better understanding of how key components of the body’s immune system find intruding or damaged cells, which could lead to novel therapeutic approaches against viral infection and cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE